^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CJRB-101

i
Other names: CJRB-101
Associations
Company:
CJ Biosci
Drug class:
Microbiome modulator
Associations
11ms
Enrollment open • Combination therapy • Metastases
|
BRAF (B-raf proto-oncogene)
|
PD-L1 expression • BRAF mutation • BRAF V600
|
Keytruda (pembrolizumab) • CJRB-101
over1year
New P1/2 trial • Combination therapy • Metastases
|
BRAF (B-raf proto-oncogene)
|
PD-L1 expression • BRAF mutation • BRAF V600
|
Keytruda (pembrolizumab) • CJRB-101